LSX World Congress Europe (or LSX Europe) is the leading event for life sciences and healthcare sectors, bringing together leaders from biotech, medtech, pharmatech, and digital health industries. Tailored for early to growth-stage companies, including those in the seed to Series B funding stages, the event connects C-suite executives, founders, and senior decision-makers with investors, strategic partners, and industry experts. Through high-quality content, targeted networking opportunities, and investor engagement, LSX World Congress Europe empowers companies to scale, secure funding, and drive innovation. Whether you're a startup or a growth-stage business, this event is your gateway to building impactful partnerships and accelerating growth in the life sciences ecosystem.

LSX World Congress Europe (or LSX Europe) takes place 25-26 March 2026 at the Lisbon Congress Centre, Lisbon, Portugal.

We are also the only event partnered with BIO-Europe Spring (23-25 March) for 2026, part of Spring Innovation Week, offering unparalleled opportunities to connect with life sciences and healthcare leaders, investors, and strategic partners in Lisbon.

LSX Europe brings together a diverse and influential audience from across the life sciences and healthcare ecosystem. Attendees range from early to growth-stage companies, from start-ups in the seed to Series B funding stages, to established industry leaders and investors, including:

• C-suite executives: CEOs, CFOs, COOs, and other senior leaders driving strategy and decision-making.
• Founders and entrepreneurs: Visionaries leading innovative biotech, medtech, pharmatech, and digital health companies.
• Investors and venture capitalists: Professionals actively seeking opportunities to fund and partner with early to growth-stage companies.
• Strategic partners and service providers: Organizations offering expertise, resources, and solutions to support business growth.

Whether you’re a start-up looking to scale, a growth-stage company seeking funding, or an established player exploring innovation, LSX World Congress Europe is the ultimate platform to connect, collaborate, and accelerate your journey in the life sciences and healthcare industries.

Our speaking programme features speakers from a diverse mix of biopharmaceutical, pharmaceutical, medtech, healthtech, and corporate venture capital firms. Including:

• Jazz Pharmaceuticals

• Baxter

• Elekta

• M Ventures

• Novo Holdings

• High‑Tech Gründerfonds (HTGF)

• Gilde Healthcare

• Forbion

• Untethered Ventures

• Solventum

• WeHealth / Servier

A Pre-Day on Tuesday 24 March focuses on CEO and Partnering Forums as closed-door roundtable discussions - View Pre-Day Agenda here.

The main event is held over two days (Wednesday 25 - Thursday 26 March 2026) with the following:

• Thought leadership and expert speakers in biotech, medtech, and pharmatech including: 90-minute expert insight sessions with interactive Q&A, panel discussions with industry leaders, and real-world case studies and practical frameworks
• Qualified 1:1 partnering as a core feature to facilitate deal conversations
• Networking breaks, exhibitor booths or innovation showcases
• Opportunities to present your company, pitch to investors, or sponsor the event

Absolutely! LSX Europe is particularly valuable for early to growth-stage companies, including start-ups in the seed to Series B funding stages. Our event offers tailored content, networking opportunities, and access to investors and partners who are actively seeking to collaborate with innovative companies at these critical stages of development.

• Identify high-potential biotech, medtech and pharmatech innovators seeking funding.
• Use the 1:1 partnering platform to connect with start-ups that fit your portfolio.
• Attend investment-focused sessions to spot new trends and co-investment opportunities (knowing where capital is flowing, and which areas are under the radar)
• Attend early innovation & translation sessions (to spot de risked or platform opportunities).
• Network with fellow investors, corporates and BD leaders to expand your deal pipeline.
• Focus on companies with strong science and clear commercial pathways.

Please check our terms and conditions on the Investor Qualification page below:

Here’s some tips:

• Prepare a short “elevator pitch” summarising your platform, indication, value creation plan.
• Research the investors and pharma companies who will be attending and prioritise networking with them.
• Attend sessions relevant to your growth stage and market focus.
• Use partnering app to pre-book 1:1 meetings early to secure time with investors and partners.
• Be visible – Ask questions in panels that show you are thinking about commercial strategy/market access, engage in networking breaks and showcase opportunities.
• Follow up quickly to turn new connections into lasting relationships.
  
  

LSX Europe is organized by Informa Connect, part of Informa PLC.

Our event is co-located with BIO-Europe Spring as part of Spring Innovation Week, creating a unique opportunity to connect with leaders across the life sciences innovation and investment ecosystem. Please note, this is the official site for LSX Europe, and we are not affiliated with any other organizations or websites that may claim to be aligned with our event. Browse more of our biotech and pharma events here.